Evaluation of Definitive Chemoradiotherapy Versus Radical Esophagectomy in Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma

The standard treatment for patients with clinical T1bN0M0 esophageal squamous cell carcinoma is radical esophagectomy. Definitive chemoradiotherapy regarded as a option, and recently, good outcomes of this have been reported. This study compared prognosis after definitive From January 2011 to December 2019, 68 consecutive who were diagnosed enrolled investigated retrospectively. Patients classified into two groups whether treated by surgery or chemoradiotherapy. Survival compared, subsequent therapies recurrence also investigated. Among patients, 39 underwent 29 received No significant difference was noted in overall survival between the groups. However, rate 5-year recurrence-free significantly lower group than that (91.1 vs. 62.7%, hazard ratio 3.976, 95% confidence interval 1.076–14.696, p = 0.039). had local endoscopic submucosal dissection photodynamic therapy salvage therapies, which resulted no disease progression prognosis. may become promising alternative comparable esophagectomy carcinoma. Early detection frequent follow-up important control within recurrence, lesions could contribute long-term survival.